Design and Pilot Implementation of a Chatbot to Support Breast Cancer Screening Among Black Women

ConditionBreast Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age40-74
SponsorUniversity of Washington

About this trial

Black women are more likely than White women to be diagnosed at later stages and to die from breast cancer. Increasing breast cancer screening rates could help improve early detection of and survival from breast cancer. To this end, this study seeks to implement and evaluate a culturally tailored chatbot intervention to increase breast cancer screening and address inequities among Black women using community-based research approaches.

We will conduct a pilot randomized quality improvement trial to test the efficacy of a chatbot outreach intervention, which provides breast cancer screening education and direct links to scheduling, on increasing breast cancer screening completion among Black women who receive primary care at the University of Washington (UW) Medicine. We hypothesize that compared to women who receive usual care, women who receive this novel chatbot outreach will have higher breast cancer screening completion rates at 90-days. In addition to quantitative assessment of chatbot effectiveness, we will also qualitatively evaluate chatbot acceptability, feasibility, and message relevance through interviews with a small group of participants about their experiences with the chatbot.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 40 through 74 years at the time of eligibility assessment.

Assigned female at birth.

An active UW Medicine primary-care patient and included in the UW Medicine population-health breast cancer screening outreach population.

Due for breast cancer screening, defined as having no documented mammogram within the prior 24 months, based on the UW Medicine adaptation of the NCQA HEDIS breast cancer screening measure.

Disqualifiers

History of bilateral mastectomy.

EHR diagnosis or indicator of palliative care, advanced illness, or frailty.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Chatbot

    Other intervention

    Chatbot-based outreach that provides breast cancer screening education, allows participants to learn more about screening, and offers direct mammography scheduling through the chatbot

Treatment groups

873 Participants
are divided into 2 treatment groups
Group A: Usual careNo intervention 0 interventions
Group B: Chatbot interventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Proportion of participants completing BCS 90 days after initial outreach

Time frame
90-days

Secondary outcomes

1

Proportion of participants who schedule or complete BCS 90 days after initial outreach

Time frame
90-days

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Washington

Lead sponsor

Novartis Pharmaceuticals

Collaborator

National Comprehensive Cancer Network

Collaborator

This trial is not recruiting at the moment. You can still explore other options: